EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
    3.5.1.19 | Tuberculosis |
330364 |
Cytochemical and biological properties of Mycobacterium bovis BCG. |
diagnostic usage
unassigned |
3
0 |
| 3.5.1.19 | Tuberculosis |
8640557 |
Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus. |
therapeutic application
unassigned |
1
0 |
| 3.5.1.19 | Tuberculosis |
8726014 |
Identification, cloning, and expression of the Escherichia coli pyrazinamidase and nicotinamidase gene, pncA. |
diagnostic usage
unassigned |
3
0 |
| 3.5.1.19 | Tuberculosis |
8968889 |
Rapid differentiation of bovine and human tubercle bacilli based on a characteristic mutation in the bovine pyrazinamidase gene. |
diagnostic usage
ongoing research
therapeutic application
unassigned |
3
2
1
0 |
| 3.5.1.19 | Tuberculosis |
9055989 |
Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis. |
therapeutic application
unassigned |
1
0 |
| 3.5.1.19 | Tuberculosis |
9353938 |
The pncA gene from naturally pyrazinamide-resistant Mycobacterium avium encodes pyrazinamidase and confers pyrazinamide susceptibility to resistant M. tuberculosis complex organisms. |
ongoing research
therapeutic application
unassigned |
2
1
0 |
| 3.5.1.19 | Tuberculosis |
9493394 |
Extracellular enzyme activities potentially involved in the pathogenicity of Mycobacterium tuberculosis. |
diagnostic usage
ongoing research
unassigned |
3
1
0 |
| 3.5.1.19 | Tuberculosis |
9692180 |
Mutation in pncA is a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis. |
causal interaction
ongoing research
unassigned |
1
2
0 |
| 3.5.1.19 | Tuberculosis |
9811635 |
Purification, gene cloning, targeted knockout, overexpression, and biochemical characterization of the major pyrazinamidase from Mycobacterium smegmatis. |
ongoing research
therapeutic application
unassigned |
3
1
0 |
| 3.5.1.19 | Tuberculosis |
10049264 |
Reduced pyrazinamidase activity and the natural resistance of Mycobacterium kansasii to the antituberculosis drug pyrazinamide. |
therapeutic application
unassigned |
1
0 |
